Skip to main content

Table 1 Characteristics for all subjects and by human milk intake

From: Growth in VLBW infants fed predominantly fortified maternal and donor human milk diets: a retrospective cohort study

  

Group by proportion of enteral intake as human milk

 
 

 All subjects 

 <25% 

 25-50% 

 50-75% 

 >>75% 

 p value*

 

n = 171

n = 17

n = 30

n = 36

n = 88

 

Male sex n (%)

85 (49)

6 (35)

12 (40)

21 (58)

45 (51)

0.52

Gestational age, weeks, median (IQR)

27

28.43

26.86

26.64

27

0.63

 

(25.4, 28.9)

(25.4, 29.6)

(25.4, 29.0)

(25.7, 28.5)

(25.6, 28.8)

 

Birthweight, g, median (IQR)

889

1083

861

848

880

0.31

 

(724, 1064)

(778, 1184)

(736, 1091)

(717, 1011)

(719, 1052)

 

Birthweight z-score, median (IQR)

−0.40

−0.32

−0.19

−0.48

−0.45

0.98

 

(−0.99, 0.29)

(−0.52, 0.05)

(−0.89, 0.12)

(−1.15, 0.29)

(−0.93, 0.33)

 

SGA at birth n (%)

27 (16)

3 (18)

4 (13)

7 (19)

13 (15)

0.89

Maternal antenatal steroids n (%) n = 163

132 (81)

14 (88)

22 (79)

30 (88)

65 (78)

0.55

Postnatal dexamethasone n (%)

53 (31)

5 (29)

10 (30)

12 (34)

25 (28)

0.90

Age at first enteral feeding, days, median (IQR)

2 (1, 2)

2 (1, 2)

2 (1, 3)

2 (1, 2)

2 (1, 2)

0.34

Age at human milk fortification, days, median (IQR) (n = 161)

14 (9, 22)

10 (6, 25)

19 (8, 25)

13 (10, 20)

14 (9, 21)

0.74

Central line days, median (IQR)

22

17

26

22

20

0.008

 

(13, 33)

(9, 27)

(15, 37)

(14, 34)

(13, 31)

 

NEC n (%)

3 (2)

0 (0)

0 (0)

1 (3)

2 (2)

1

ROP n (%)

63 (38)

7 (47)

14 (50)

11 (33)

27 (33)

0.32

PDA n (%)

85 (49)

5 (29)

16 (53)

17 (49)

45 (51)

0.40

Sepsis n (%)

26 (15)

3 (18)

6 (20)

9 (25)

8 (9)

0.09

IVH n (%)

31 (18)

1 (6)

4 (13)

2 (6)

23 (27)

0.02

Oxygen at discharge n (%)

116 (67)

11 (65)

20 (67)

23 (64)

60 (68)

0.97

Postmenstrual age at discharge, weeks, median (IQR)

38.7 (37.1, 40.4)

37.85 (37.1, 40.9)

39.92 (36.9, 41.3)

39.21 (37.42, 40.79)

38.27 (3.07, 39.6)

0.01

Length of stay, days, median (IQR)

79 (63, 96)

71 (56, 124)

89 (63, 103)

84 (69, 100)

77 (61, 94)

0.18

  1. * Chi-squared, Fisher’s exact test, or ANOVA across all groups.